Related Experiment Video
Updated: Feb 22, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Associations between circulating macrophage migration inhibitory factor (MIF) levels and rheumatoid arthritis, and
Sang-Cheol Bae1, Young Ho Lee2
1Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea.
Aim:
To systematically review evidence regarding the relationship between circulating macrophage migration inhibitory factor (MIF) levels and rheumatoid arthritis (RA), and the association between MIF gene polymorphisms and RA susceptibility.
Design:
We performed a meta-analysis on data of serum/plasma MIF levels in patients with RA and in controls, and on associations between the MIF-173 C/G and -794CATT5-8 polymorphisms and RA susceptibility.
Patients:
Twelve studies, comprising a total of 362 RA cases and 531 controls evaluated for MIF levels, and 2367 RA cases and 2395 controls evaluated for MIF polymorphisms, were included.
Results:
MIF levels were significantly higher in the RA group than in the control group (standardised mean difference (95% CI) 0.923 (0.766 to 1.080), p<0.001). Stratification by ethnicity revealed significantly higher MIF levels in the RA group in Caucasian, Asian and Latin American populations. MIF levels were significantly higher in patients with RA, regardless of adjustment, sample size or data type evaluated. RA was identified to be significantly associated with the MIF-173 C allele (OR (95% CI) 1.271 (1.141 to 1.416), p<0.001), as well as with the -794CATT7 allele (OR (95% CI) 1.229 (1.084 to 1.415), p=0.002) and the -794CATT7-MIF-173C haplotype RA (OR (95% CI) 1.433 (1.138 to 1.805), p=0.002).
Conclusions:
Our meta-analyses revealed significantly higher circulating MIF levels in patients with RA, and found evidence of associations between the MIF-173 C/G and -794CATT5-8 polymorphisms and RA susceptibility.
Insights
This study found higher macrophage migration inhibitory factor (MIF) levels in rheumatoid arthritis (RA) patients. Genetic variations in the MIF gene are also linked to increased RA susceptibility, suggesting MIF
Area of Science:
- Immunology
- Genetics
- Rheumatology
Background:
- Rheumatoid arthritis (RA) is a chronic autoimmune disease.
- Macrophage migration inhibitory factor (MIF) is a key inflammatory cytokine implicated in RA pathogenesis.
Purpose of the Study:
- To systematically review evidence on circulating MIF levels in RA patients.
- To investigate the association between MIF gene polymorphisms and RA susceptibility.
Main Methods:
- Meta-analysis of serum/plasma MIF levels in RA patients versus controls.
- Meta-analysis of associations between MIF gene polymorphisms (-173 C/G and -794CATT5-8) and RA susceptibility.
- Inclusion of twelve studies with data from 362 RA cases and 531 controls for MIF levels, and 2367 RA cases and 2395 controls for polymorphisms.
Main Results:
- Significantly higher MIF levels were observed in RA patients compared to controls (SMD 0.923, P<0.001).
- Elevated MIF levels in RA patients were consistent across Caucasian, Asian, and Latin American populations.
- RA susceptibility was significantly associated with the MIF-173 C allele (OR 1.271, P<0.001), the -794CATT7 allele (OR 1.229, P=0.002), and a specific haplotype (P=0.002).
Conclusions:
- Circulating MIF levels are significantly elevated in individuals with rheumatoid arthritis.
- Specific MIF gene polymorphisms (-173 C/G and -794CATT5-8) are associated with an increased susceptibility to developing RA.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
The JAK-STAT Signaling Pathway

